BUSULPHAN-MELPHALAN VERSUS CARBOPLATIN-ETOPOSIDE-MELPHALAN CONDITIONING REGIMEN IN CHILDREN WITH NEUROBLASTOMA UNDERWENT AUTOLOGOUS STEM CELL TRANSPLANTATION

被引：0
|
作者：
Atas, E. [1 ]
Kesik, V. [1 ]
Babacan, O. [1 ]
Korkmazer, N. [2 ]
机构：
[1] Gulhane Mil Med Acad, Dept Pediat Oncol, Ankara, Turkey
[2] Gulhane Mil Med Acad, Dept Pediat, Ankara, Turkey
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
PH-P219
引用
收藏
页码：S206 / S206
页数：1
相关论文
共 50 条
  • [21] Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
    Okay, Mufide
    Buyukasik, Yahya
    Demiroglu, Haluk
    Malkan, Umit Yavuz
    Ciftciler, Rafiye
    Aladag, Elifcan
    Aksu, Salih
    Haznedaroglu, Ibrahim Celalettin
    Sayinalp, Nilgun
    Ozcebe, Osman Ilhami
    Goker, Hakan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2019, 49 (04) : 985 - 992
  • [22] Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma
    Desai, A. V.
    Heneghan, M. B.
    Li, Y.
    Bunin, N. J.
    Grupp, S. A.
    Bagatell, R.
    Seif, A. E.
    BONE MARROW TRANSPLANTATION, 2016, 51 (09) : 1204 - 1210
  • [23] Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma
    A V Desai
    M B Heneghan
    Y Li
    N J Bunin
    S A Grupp
    R Bagatell
    A E Seif
    Bone Marrow Transplantation, 2016, 51 : 1204 - 1210
  • [24] Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)
    Jo, Jae-Cheol
    Kim, Jin Seok
    Lee, Je-Hwan
    Lee, Jung-Hee
    Lim, Sung-Nam
    Lee, Sang Min
    Yoon, Sung-Soo
    Kim, In-Ho
    Bae, Sung Hwa
    Lee, Yoo Jin
    Choi, Yunsuk
    Lee, Won-Sik
    BONE MARROW TRANSPLANTATION, 2020, 55 (07) : 1466 - 1468
  • [25] Busulfan, etoposide, cytarabine and melphalan (BUEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-hodgkin lymphoma (NHL)
    Jo, Jae-Cheol
    Kim, Jin-Seok
    Lee, Je-Hwan
    Lee, Jung-Hee
    Im, Seong Nam
    Lee, Won-Sik
    Lee, Sang-Min
    Yoon, Sung-Soo
    Kim, In-Ho
    Choi, Yun Suk
    Bae, Seong Hwa
    BONE MARROW TRANSPLANTATION, 2019, 54 : 209 - 210
  • [26] Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)
    Jae-Cheol Jo
    Jin Seok Kim
    Je-Hwan Lee
    Jung-Hee Lee
    Sung-Nam Lim
    Sang Min Lee
    Sung-Soo Yoon
    In-Ho Kim
    Sung Hwa Bae
    Yoo Jin Lee
    Yunsuk Choi
    Won-Sik Lee
    Bone Marrow Transplantation, 2020, 55 : 1466 - 1468
  • [27] New conditioning regimen with idarubicin and melphalan in autologous PBPC transplantation
    Musso, M
    Porretto, F
    Crescimanno, A
    Bondi, F
    Polizzi, V
    Scalone, R
    Cajozzo, A
    Mariani, G
    BONE MARROW TRANSPLANTATION, 1998, 21 : S97 - S97
  • [28] Busulphan and melphalan conditioning for autologous BM/PBSC transplantation in multiple myeloma.
    Clark, A
    Mitchell, L
    Alcorn, M
    Tansey, P
    Cook, G
    Franklin, IM
    BONE MARROW TRANSPLANTATION, 1998, 21 : S99 - S99
  • [29] Bortezomib after high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with multiple myeloma: A comparison with the historical conditioning regimen with melphalan alone
    Ferini, G. A.
    Arbelbide, J. A.
    Basquiera, A. L.
    Nucifora, E.
    Schutz, N.
    Otero, V.
    Fantl, D.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S461 - S462
  • [30] High-dose etoposide, cytarabine and melphalan as conditioning regimen for autologous stem cell transplantation in patients with refractory or relapsed Hodgkin's lymphoma
    Bekadja, M. A.
    Osmani, S.
    Brahimi, M.
    Talhi, S.
    Bekadja, S.
    Belkhodja, S.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S446 - S446
12345